We are an investment and engagement platform targeting companies at the cross section of healthcare, science, and technology. Bioverge provides founders access to capital to help them push the boundaries of human healthcare, while democratizing the investing process for all individuals in the $2 trillion healthcare market.
All startups must have secured funding from a professional third party, which can include: accelerator/incubator, VC, strategic partner, professional angel group, or federal agency. This gate allows for an additional level of scientific and technical review by professionals prior to the Bioverge diligence process.
In addition to professional participation, their respective diligence efforts, and our independent review, we combine input from our network of scientific and technical subject matter experts, industry veterans, and professional investors to evaluate each opportunity from a number of unique and specialized perspectives.
For the select opportunities made available to investors, we pass along what we've learned and take care to translate the industry jargon and deep technical details into a form that can be more easily understood and related to by our investors.
As an active investor myself I found it difficult to source, diligence, and invest in novel science companies working on projects that mattered to me. There was no cohesive ecosystem focused on providing access to, overviewing in detail, and collectively supporting emerging healthcare technology companies. Bioverge was created to remove that hurdle.